These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2654792)
1. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study. Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S Oncology; 1989; 46(3):150-4. PubMed ID: 2654792 [TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy. Strum SB; McDermed JE; Liponi DF J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511 [TBL] [Abstract][Full Text] [Related]
3. High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study. Gez E; Warner-Efraty E; Ben-Yosef R; Ben-Baruch N; Yitzhaki N; Uziely B; Brufman G; Biran S Oncology; 1987; 44(4):237-9. PubMed ID: 3614813 [TBL] [Abstract][Full Text] [Related]
4. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy. Bhatia A; Tripathi KD; Sharma M Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464 [TBL] [Abstract][Full Text] [Related]
5. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. Sorbe BG Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123 [TBL] [Abstract][Full Text] [Related]
6. Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo. Pollera CF; Nardi M; Marolla P; PinnarĂ³ P; Terzoli E; Giannarelli D Am J Clin Oncol; 1989 Dec; 12(6):524-9. PubMed ID: 2589233 [TBL] [Abstract][Full Text] [Related]
7. Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial. Tsavaris N; Tsaroucha-Noutsou E; Bacoyannis C; Mylonakis N; Valilis P; Kozatsani-Halividi D; Tsoutsos H; Droufakou S; Kosmidis P Oncology; 1992; 49(6):479-83. PubMed ID: 1465288 [TBL] [Abstract][Full Text] [Related]
8. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide. Aapro MS; Plezia PM; Alberts DS; Graham V; Jones SE; Surwit EA; Moon TE J Clin Oncol; 1984 May; 2(5):466-71. PubMed ID: 6539363 [TBL] [Abstract][Full Text] [Related]
9. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research. Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin. Pollera CF; Nardi M; Marolla P; Carlini P Cancer Chemother Pharmacol; 1987; 19(4):335-8. PubMed ID: 3297376 [TBL] [Abstract][Full Text] [Related]
11. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176 [TBL] [Abstract][Full Text] [Related]
12. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536 [TBL] [Abstract][Full Text] [Related]
13. High-dose metoclopramide and dexamethasone as an antiemetic in chemotherapy of breast cancer. Gez E; Goodman S; Isacson R; Gerra C; Sulkes A Oncology; 1986; 43(3):173-5. PubMed ID: 3754627 [TBL] [Abstract][Full Text] [Related]
14. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial. Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348 [TBL] [Abstract][Full Text] [Related]
15. The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial. Richards PD; Flaum MA; Bateman M; Kardinal CG Cancer; 1986 Aug; 58(4):959-62. PubMed ID: 3521843 [TBL] [Abstract][Full Text] [Related]
16. Randomized crossover antiemetic study in cisplatin-treated patients. Comparison between high-dose i.v. metoclopramide and high-dose i.v. dexamethasone. Frustaci S; Grattoni E; Tumolo S; Crivellari D; Figoli F; Galligioni E; Veronesi A; Tirelli U; Grigoletto E Cancer Chemother Pharmacol; 1986; 17(1):75-9. PubMed ID: 3698180 [TBL] [Abstract][Full Text] [Related]
17. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues. Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294 [TBL] [Abstract][Full Text] [Related]
18. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research. J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029 [TBL] [Abstract][Full Text] [Related]